About Us
We're Siensmetrica
Our mission is to make it easy to find reliable, high quality, and trustworthy scientific information
About Us
We're Siensmetrica
Our mission is to make it easy to find reliable, high quality, and trustworthy scientific information
We're Conquering Information Overload
Let's face it, when it comes to the world of healthcare research and information, we're facing a growing crisis of trust.
Open access mandates and electronic distribution are doubling the amount of available material every eight weeks or so, but rigorous peer review takes months or years.
The result is a growing chasm between the information available, and that found to be verifiably credible, high-quality research.
No person can keep pace with all the new medical information, never mind be able to separate the reliable from the unreliable. Little wonder that there's growing skepticism and frustration among researchers, practitioners, and the healthcare community at large.
Our goal is to solve this problem by combining advanced data science, multi-vector content analysis, and artificial intelligence to mine the mountains of research and identify the most relevant, verifiable, and trustworthy information on a subject. We then put it in the hands of the professionals who need it so that they can quickly and confidently make evidence-based decisions to improve healthcare outcomes.
We're Conquering Information Overload
Let's face it, when it comes to the world of healthcare research and information, we're facing a growing crisis of trust.
Open access mandates and electronic distribution are doubling the amount of available material every eight weeks or so, but rigorous peer review takes months or years.
The result is a growing chasm between the information available, and that found to be verifiably credible, high-quality research.
No person can keep pace with all the new medical information, never mind be able to separate the reliable from the unreliable. Little wonder that there's growing skepticism and frustration among researchers, practitioners, and the healthcare community at large.
Our goal is to solve this problem by combining advanced data science, multi-vector content analysis, and artificial intelligence to mine the mountains of research and identify the most relevant, verifiable, and trustworthy information on a subject. We then put it in the hands of the professionals who need it so that they can quickly and confidently make evidence-based decisions to improve healthcare outcomes.
Our Story
Siensmetrica began not in a boardroom, but with a personal journey. When one of our co-founders faced a condition that stumped his doctors, he dove into the medical research himself, searching for answers.
What he found was a tidal wave of new studies—too vast and of varying quality for any practicing physician to navigate effectively. He saw that this information overload forces doctors to rely on outdated playbooks, delaying effective treatment and impacting patient outcomes.
Convinced there had to be a better way, the technology entrepreneur partnered with a healthcare industry veteran in 2024 to found Siensmetrica. The mission: empower clinicians by using AI to analyze and score medical research, allowing them to quickly identify the most trustworthy insights and translate them into better care.
The Team
Jeff Drake
Chairman & Co-founder
A proven high-tech leader, Mr. Drake has built and led multiple successful organizations in cybersecurity, data analytics, and AI. As founder of Access360, he oversaw its acquisition by IBM and subsequently served as Director of Software Security. He also served as EVP of Business Development at Akana (acquired by Rogue Wave), and CEO and Board Member Bitvore through its 2024 acquisition by BondWave.
Marc Toth
CEO and Co-founder
A seasoned entrepreneur, Mr. Toth has built and led multiple medical device companies from startup to successful exits. He's also an expert in raising capital and navigating mergers & acquisitions within the healthcare space. His leadership extends beyond his own ventures. He actively contributes to the industry's future as an Independent Board Member at cutting-edge companies like FibriCheck, DEO.Care, and Nudj Health.
Gregory Bolcer, PhD
Chief Technology Officer
Marvin J. Slepian, MD, JD
Chief Science Officer
Sage Osterfeld
Chief Marketing Officer
Todd Cass
Software Engineering
Diego Marino
Software Engineering
Justin Muckenthaler
Product Management
Nelson Torres
Software Engineering
Guillermo Rodriguez
Software Engineering
Our Advisors
Dr. Jeffrey Curtis, MD, MPH
Dr. Curtis is a Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB). He holds the Harbert-Ball Endowed Professorship in Rheumatology and leads the UAB Pharmacoepidemiology and Pharmacoeconomics Research (PEER) Unit.
Dr. Vishal Gupta MD, MPH
Dr. Gupta is Medical Director at Structural Heart Program, where he oversees the delivery of cutting-edge cardiovascular interventions and therapies to patients with complex heart conditions. He has been involved in the development of a number of medical devices, and his perspective on patient safety and procedural practicality led to the conception of the Anchor Balloon technique for stent delivery.
Stephen Gurczynski, PhD
Mr. Gurczynski is an Assistant Research Professor of Microbiology and Immunology at the University of Michigan Medical Research Institute. His primary focus is on virology and microbiology. He has 39 publications and 8 NIH grants.
Phillip Levy, MD, MPH
Dr. Levy is a professor of emergency medicine and a leading cardiovascular disease researcher who has overseen more than 110 funded studies from various entities including the CDC, AHA, and NIH, since arriving at Wayne State in 2002. His work has been highly influential with an h-index of 52 and more than 300 published manuscripts and textbook chapters, including senior authorship on numerous guidelines, scientific statements and consensus papers.
Francois P. Modave, MS, PhD
Dr. Modave is trained in mathematics and artificial intelligence and is a Professor in the Department of Pediatrics at Atrium Health – Wake Forest Baptist. He is a member of the Center for Remote Health Monitoring and the Center for AI Research. His work is focused on the use of digital health and AI to improve clinical outcomes and reduce health inequities. He has been funded by the National Institutes of Health, the National Science Foundation, and the Agency for Healthcare and Research Quality.
Dr. Adam Rubenstein, MD
Dr. Rubenstein is the Director of Anesthesia Services at Henry Ford Health System. He is a clinical anesthesiologist and educator for Henry Ford Health. He is the former Service Chief for the Department of Anesthesiology, Perioperative, and Pain Medicine at Henry Ford Health Jackson.
James Salanty
Mr. Salanty has over 30 years' experience as a biopharmaceutical professional with a number of leading pharmaceutical firms including TAP pharmaceuticals, Abbott Labs, and AbbVie. During his 10-plus years with Abbvie Vice President of Rheumatology and later its Vice President Immunology Strategy.
